Chymoral forte
Reading File
Finding Sources
Searching the Web
Chymoral forte trypsin chymotrypsin uses dosage mechanism of action
Finding Sources
Searching PubMed
trypsin chymotrypsin anti-inflammatory clinical efficacy
Here is a complete overview of Chymoral Forte:
Chymoral Forte
Composition
Each enteric-coated tablet contains:
- Trypsin + Chymotrypsin: 1,00,000 Armour units of enzymatic activity
- Trypsin : Chymotrypsin ratio = approximately 6:1
Manufactured by Torrent Pharmaceuticals Ltd.
Mechanism of Action
Both trypsin and chymotrypsin are serine proteases (proteolytic enzymes):
- Trypsin is a natural pancreatic enzyme that cleaves peptide bonds at the C-terminal side of lysine and arginine residues.
- Chymotrypsin is also pancreatic in origin and cleaves preferentially at aromatic and bulky hydrophobic residues (phenylalanine, tyrosine, tryptophan).
Together, they work by:
- Breaking down proteins involved in the inflammatory cascade into smaller, absorbable fragments
- Degrading fibrin and necrotic tissue at injury sites, improving microcirculation
- Reducing edema by enhancing lymphatic drainage and blood flow to swollen areas
- Removing damaged tissue (debridement effect), which accelerates healing
- Degrading inflammatory mediators (kinins, bradykinin) directly, reducing pain signals
The tablet is enteric-coated so it bypasses the stomach and the enzymes are absorbed intact from the small intestine into the systemic circulation to act on peripheral tissues.
Indications / Uses
| Category | Conditions |
|---|---|
| Post-surgical | Post-operative wounds, edema after abdominal hysterectomy, maxillofacial surgery, open reduction of fractures, episiotomy |
| Trauma / Orthopedic | Soft tissue injuries, sprains, strains, bruises, lacerations, hematomas, fractures, dislocations |
| Dental | Post-tooth extraction, peri-apical abscess |
| Gynecological | Pelvic inflammatory disease |
| Neurological | Sciatica (due to intervertebral disc herniation) |
| Respiratory | Chronic respiratory disorders with excess mucus (mucolytic effect) |
| Vascular | Hemorrhoids (piles), thrombophlebitis |
| Oncology support | Supportive therapy alongside chemotherapy/radiation |
Dosage
- Adults: 1-2 tablets 4 times daily, taken 30 minutes before meals on an empty stomach
- Typical course: 7-10 days
- No established dosing for pediatric or geriatric populations
Side Effects
- Nausea, vomiting, diarrhea (GI disturbances - most common)
- Allergic reactions (rash, urticaria) - rare
- Hypersensitivity reactions in sensitive individuals
Contraindications
- Hypersensitivity to trypsin or chymotrypsin
- Active peptic ulcer disease
- Severe hepatic or renal impairment
- Pregnancy and lactation (safety not established)
- Coagulation disorders / patients on anticoagulants (theoretical interaction)
Precautions
- Should not be taken with meals (food reduces enzyme absorption)
- Should not be chewed or crushed (enteric coating is essential)
- Use with caution in patients with known drug allergies
Comparison: Chymoral Forte vs. Serratiopeptidase
| Feature | Chymoral Forte | Serratiopeptidase |
|---|---|---|
| Composition | Trypsin + Chymotrypsin (2 enzymes) | Single enzyme |
| Activity | 1,00,000 Armour units | Measured in SU units |
| Administration | 30 min before meals | Usually with/after meals |
| Origin | Pancreatic (bovine/porcine) | Bacterial (Serratia marcescens) |
| Primary use | Post-surgical edema, trauma | Similar anti-inflammatory use |
Clinical Evidence
A 2023 RCT in the Journal of Endodontics confirmed trypsin-chymotrypsin reduces postoperative pain after endodontic treatment. Earlier clinical studies (cited in a PMC review of trypsin:chymotrypsin in tissue repair) showed:
- Bruise resolution improved from 10-15 days to 8-12 days
- Comparable or superior efficacy to serratiopeptidase in post-fracture surgery recovery (measuring erythema, edema, pain, wound discharge)
- Benefit in sciatica patients who failed analgesics, physiotherapy, and local anesthetic injections
Key clinical pearl: Chymoral Forte is classified as an enzyme-based anti-inflammatory rather than a conventional NSAID. It does not inhibit COX pathways, so it carries no risk of GI ulceration from prostaglandin suppression, making it a useful adjunct (not replacement) in post-surgical and trauma settings.
This is a shared conversation. Sign in to Orris to start your own chat.